Aristeia Capital’s AEON Biopharma Inc AEON.WS Stock Holding History

Aristeia Capital’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-164,255	Closed	-$250K	–	420
2024 Q1	$250K	Sell	164,255 -194,078	-54%	-$119K	0.01%	158
2023 Q4	$31.3K	Hold	358,333	–	–	﹤0.01%	126
2023 Q3	$57.3K	Buy	358,333 +25,000	+8%	+$3.54K	﹤0.01%	134
2023 Q2	$28.3K	Hold	333,333	–	–	﹤0.01%	184
2023 Q1	$21.9K	Hold	333,333	–	–	﹤0.01%	301
2022 Q4	$12.5K	Hold	333,333	–	–	﹤0.01%	438
2022 Q3	$25K	Hold	333,333	–	–	﹤0.01%	549
2022 Q2	$52K	Hold	333,333	–	–	﹤0.01%	507
2022 Q1	$105K	Buy	+333,333	New	+$138K	﹤0.01%	542

Aristeia Capital's AEON.WS Position: Q2 2024 in Review

Aristeia Capital sold out of AEON Biopharma Inc (AEON.WS) in Q2 2024, closing a stake of 164,255 shares — an estimated $250K sold.

Aristeia Capital first reported a position in AEON.WS in Q1 2022 and held it in 9 quarters. The position peaked at $250K in Q1 2024. 0 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2024.

Aristeia Capital reported no remaining AEON Biopharma Inc position as of Q2 2024 after selling out during the quarter.
Aristeia Capital sold 164,255 AEON Biopharma Inc shares in Q2 2024, an estimated $250K.
Aristeia Capital first reported a position in AEON Biopharma Inc in Q1 2022 and held it in 9 quarters.
Aristeia Capital's AEON Biopharma Inc position peaked at $250K in Q1 2024.
0 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2024.

Based on Aristeia Capital's 13F filing for Q2 2024, filed 14 Aug 2024.